Molecular modelling design, synthesis and cytotoxic evaluation of certain substituted 2-(3,4,5-triacetoxybenzoylamino)benzo[d]thiazole and 2-(galloylamino)benzo[d]thiazole derivatives having potential topoisomerase-I inhibitory activity

References

• Liu LF. DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 1989;58:351–375.
   PubMed Web of Science ®Google Scholar
• Vilaivan T, Lowe G. A novel pyrrolidinyl PNA showing high sequence specificity and preferential binding to DNA over RNA. J Am Chem Soc 2002;124:9326–9327.
   PubMed Web of Science ®Google Scholar
• D’Costa M, Kumar V, Ganesh KN. Synthesis of 4(S)-(N-Boc-amino)-2(S/R)-(thymin-1-ylmethyl)-pyrrolidine-N-1-acetic acid: A novel cyclic PNA with constrained flexibility. Tetrahedron Lett 2002;43:883–886.
   Google Scholar
• Sheigeyasu M, Kuwahara M, Sisido M, Ishikawa T. Synthesis and DNA binding property of a novel peptide nucleic acid that contains cis-4-adeninyl-L-prolinol unit. Chem Lett 2001;634–635.
   Google Scholar
• Ferro AM, Olivera BM. Poly(ADP-ribosylation) of DNA topoisomerase I from calf thymus. J Biol Chem 1984;259:547–554.
   PubMedGoogle Scholar
• Muller MT, Spitzner JR, DiDonato JA, Mehta VB, Tsutsui K, Tsutsui K. Single-strand DNA cleavages by eukaryotic topoisomerase II. Biochemistry 1988;27:8369–8379.
   PubMed Web of Science ®Google Scholar
• Nitiss JL. Investigating the biological functions of DNA topoisomerases in eukaryotic cells. Biochim Biophys Acta 1998;1400:63–81.
   PubMed Web of Science ®Google Scholar
• Tobey RA, Oishi N, Crissman HA. Cell cycle synchronization: Reversible induction of G2 synchrony in cultured rodent and human diploid fibroblasts. Proc Natl Acad Sci USA 1990;87:5104–5108.
   PubMedGoogle Scholar
• Woynarowski JM, McHugh M, Sigmund RD, Beerman TA. Modulation of topoisomerase II catalytic activity by DNA minor groove binding agents distamycin, Hoechst 33258, and 4’,6-diamidine-2-phenylindole. Mol Pharmacol 1989;35:177–182.
   PubMed Web of Science ®Google Scholar
• McHugh MM, Woynarowski JM, Sigmund RD, Beerman TA. Effect of minor groove binding drugs on mammalian topoisomerase I activity. Biochem Pharmacol 1989;38:2323–2328.
   PubMed Web of Science ®Google Scholar
• Tewey KM, Rowe TC, Yang L, Halligan BD, Liu LF. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 1984;226:466–468.
   PubMed Web of Science ®Google Scholar
• Nelson EM, Tewey KM, Liu LF. Mechanism of antitumor drug action: Poisoning of mammalian DNA topoisomerase II on DNA by 4’-(9-acridinylamino)-methanesulfon-m-anisidide. Proc Natl Acad Sci USA 1984;81:1361–1365.
   PubMed Web of Science ®Google Scholar
• Tewey KM, Chen GL, Nelson EM, Liu LF. Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J Biol Chem 1984;259:9182–9187.
   PubMed Web of Science ®Google Scholar
• Hsiang YH, Hertzberg R, Hecht S, Liu LF. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 1985;260:14873–14878.
   PubMed Web of Science ®Google Scholar
• Yamashita Y, Kawada S, Fujii N, Nakano H. Induction of mammalian DNA topoisomerase I and II mediated DNA cleavage by saintopin, a new antitumor agent from fungus. Biochemistry 1991;30:5838–5845.
   PubMed Web of Science ®Google Scholar
• Chow KC, Macdonald TL, Ross WE. DNA binding by epipodophyllotoxins and N-acyl anthracyclines: Implications for mechanism of topoisomerase II inhibition. Mol Pharmacol 1988;34:467–473.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Yahara S, Hashimoto F, Uyeda M. Inhibitory activities of (-)-epigallocatechin-3-O-gallate against topoisomerases I and II. Biol Pharm Bull 2001;24:1088–1090.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Shono F, Kai H, Uno T, Uyeda M. Inhibition of topoisomerases by fatty acids. J Enzym Inhib 2000;15:357–366.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Nagao K, Monnai Y, Yagi A, Uyeda M. Topostatin, a novel inhibitor of topoisomerases I and II produced by Thermomonospora alba strain No. 1520. I. Taxonomy, fermentation, isolation and biological activities. J Antibiot 1998;51:991–998.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Yahara S, Kido Y, Nagao K, Hatano Y, Uyeda M. Topostatin, a novel inhibitor of Topoisomerases I and II produced by Thermomonospora alba strain No. 1520. II. Physico-chemical properties and structure elucidation. J Antibiot 1998;51:999–1003.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Yamaizumi M, Tateishi S, Monnai Y, Uyeda M. Topostatin, a novel inhibitor of topoisomerases I and II produced by Thermomonospora alba strain No. 1520. III. Inhibitory properties. J Antibiot 1998;52:60–465.
   Google Scholar
• Suzuki K, Doi S, Yahara S, Uyeda M. 2070-DTI, a topoisomerase inhibitor produced by Streptomyces sp. strain No. 2070. J Enzyme Inhib Med Chem 2003;18:497–503.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Siddique T, Nishimura H, Sekimoto J, Uyeda M. Inhibition of DNA topoisomerases by microbial inhibitors. J Enzym Inhib 1998;13:41–55.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Sekimoto J, Siddique T, Kamiya A, Uyeda M. Macrostatin, a novel macromolecular inhibitor of topoisomerases produced by Streptomyces avermitilis no. C-127. J Enzym Inhib 1998;14:69–83.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Yahara S, Maehata K, Uyeda M. Isoaurostatin, a novel topoisomerase inhibitor produced by Thermomonospora alba. J Nat Prod 2001;64:204–207.
   PubMed Web of Science ®Google Scholar
• Abdel-Aziz M, Matsuda K, Otsuka M, Uyeda M, Okawara T, Suzuki K. Inhibitory activities against topoisomerase I and II by polyhydroxybenzoyl amide derivatives and their structure-activity relationship. Bioorg Med Chem Lett 2004;14:1669–1672.
   PubMed Web of Science ®Google Scholar
• Ioanoviciu A, Antony S, Pommier Y, Staker BL, Stewart L, Cushman M. Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis. J Med Chem 2005;48:4803–4814.
   PubMedGoogle Scholar
• Park KD, Lee SG, Kim SU, Kim SH, Sun WS, Cho SJ et al. Anticancer activity of 3-O-acyl and alkyl-(-)-epicatechin derivatives. Bioorg Med Chem Lett 2004;14:5189–5192.
   PubMedGoogle Scholar
• El-Telbany F, Essaway M, Ismail MAH, El-Kersh T. A simple one-step synthesis of some new 4(6-substituted benzothiazol-2-yl)-1-thia-4-azaspiro[5:4]decan-3-one derivatives as potential antimicrobial agents. Egypt J Pharm Sci 1987;28:33–40.
   Google Scholar
• Ye J, Abiman P, Crossley A, Jones JH, Wildgoose GG, Compton RG. Building block syntheses of gallic acid monomers and tris-(O-gallyl)-gallic acid dendrimers chemically attached to graphite powder: A comparative study of their uptake of Al(III) ions. Langmuir 2010;26:1776–1785.
   PubMed Web of Science ®Google Scholar
• Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990;82:1107–1112.
   PubMed Web of Science ®Google Scholar
• Soeksmanto A, Subroto MA, Wijaya H, Simanjuntak P. Anticancer activity test for extracts of Sarang semut plant (Myrmecodya pendens) to HeLa and MCM-B2 cells. Pak J Biol Sci 2010;13:148–151.
   PubMedGoogle Scholar
• Sheng-You H, Sam ZG, Xiaoqin Z. Scoring functions and their evaluation methods for protein–ligand docking: Recent advances and future directions. Phys Chem Chem Phys 2010;12:12899–12908.
   PubMedGoogle Scholar